The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Research Articles
[키워드] acute respiratory syndrome
antibody
Antigen
can be used
Clinical symptoms
clinically
conserved
contagious
control subjects
coronavirus
correlation
diagnostic
evaluate
human sera
hyperimmune
identify
immunodominant
individual
infected individuals
Mild
onset of symptoms
pandemic
pathogenic human coronaviruses
patients
PCR testing
population level
RBD
RBD binding antibody
RBD-binding antibody
Receptor binding domain
Recombinant SARS-CoV-2 RBD
responsible
SARS-CoV
SARS-CoV-2
SARS-CoV-2 antibody responses
SARS-CoV-2 neutralization
SARS-CoV-2 neutralizing antibody
SARS-CoV-2 patient
SARS-CoV-2-specific antibodies
sera
serologic test
serological
Serum level
severe disease
severe respiratory illness
Spread
Support
Surveillance
symptomatic patient
the RBD
the spike protein
Viral RNA
viral spike protein
virus
virus infection
zoonotic CoV
[DOI] 10.1126/sciimmunol.abc8413 PMC 바로가기 [Article Type] Research Articles
[DOI] 10.1126/sciimmunol.abc8413 PMC 바로가기 [Article Type] Research Articles